--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--------
US Stock MarketDetailed Quotes
RAPP Rapport Therapeutics
- 23.330
- +0.810+3.60%
Trading Nov 22 13:12 ET
853.33MMarket Cap-11878P/E (TTM)
23.330High22.600Low25.45KVolume22.850Open22.520Pre Close584.47KTurnover0.28%Turnover RatioLossP/E (Static)36.58MShares29.74052wk High2.64P/B214.64MFloat Cap16.55052wk Low--Dividend TTM9.20MShs Float29.740Historical High--Div YieldTTM3.24%Amplitude16.550Historical Low22.967Avg Price1Lot Size
Rapport Therapeutics Key Stats
Rapport Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Rapport Therapeutics Earnings Reports
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
